Scope and barriers in clinical trials of herbal drugs
Journal of Clinical Trials

Journal of Clinical Trials
Open Access

ISSN: 2167-0870

+44 20 3868 9735

Scope and barriers in clinical trials of herbal drugs

International Conference on Clinical Trials

July 27-29, 2015 Orlando-FL, USA

Ramandeep Kaur, Ajay Francis Chirstopher, Vikas Gupta and Parveen Bansal

Posters-Accepted Abstracts: J Clin Trials

Abstract :

Herbal products have always been an important part of the public healthcare across the globe world. A report by WHO
revealed, that approximately 65-80% of world’s population living in developing countries because of poverty and lack of
access to modern medicine depends essentially on plants for their primary healthcare because of being economical, long history
of traditional use, better compatibility with human body, minimal side effects, enhanced tolerance and more protection. Herbal
products are also prevalent in developed countries like Germany, France, Italy and U.S where required guidelines for registration
of herbal medicines exit. Approximately about 25% of all modern medicines are directly or indirectly derived from plant sources.
The current market size of herbal medicine is estimated about $80-250 billion in Europe and USA whereas in China is about $650
million. However, the contribution of developing countries in global herbal business is very poor due to the lack of quality control
and standardization measures, difficulty in preparing isolated compounds, lack of sufficient safety data including drug interaction,
poor information about the composition of herbal preparation, difficulty in selection of dosage regimen, lack of drug delivery
platforms, adulteration, difficulty in conducting randomized clinical trials, patient selection, patient motivation, comparative
placebo and end point selection, high protocol non-compliance, methodological shortcomings etc. Therefore, these pitfalls in
herbal clinical trials must be addressed to generate a sustainable natural source which could cater the ever needing demand of new
and safer treatments and in renewing the interest of pharmaceutical companies in herbal medicine research.

Biography :

Ramandeep Kaur completed her Bachelors in Pharmacy (Pandit J.R. Govt. Polytechnic, Hoshiarpur, Punjab India) in 2012. Presently she is pursuing her second
year of Masters of Science in Clinical Research from University Centre of Excellence in Research (Baba Farid University of Health Sciences, Faridkot). She has
one international publication in Integrative Medicine Research Journal.